Walters 2013.
Study characteristics | |
Methods | Design: CRT Follow‐up: 12 months Control group: usual care |
Participants |
Recruitment: general practice Assessed for eligibility: 1207 Randomly assigned: SM: 90; UC: 92 Completed: SM: 74; UC: 80 Mean age: SM: 68.2 (SD 7.9) years; UC: 67.3 (SD 7.6) years Gender (% male): SM: 54; UC: 51 COPD diagnosis: postbronchodilator FEV1/FVC < 0.7, FEV1 30‐80% Inclusion of participants in acute phase: not reported Major inclusion criteria: smoking history > 10 pack‐years, postbronchodilator FEV1/FVC < 0.7, FEV1 30% to 80%; able to complete procedures and provide informed consent Major exclusion criteria: unable to participate in self‐care activities due to mental or physical incapacity, end‐stage cancer, poor English language skills and nursing home resident |
Interventions |
Mode: mentor telephone call sessions Duration: 16 individual phone calls (30 min each) Professional: community health nurses Assignment of case managers: yes, accessible to participants during the complete follow‐up period Self‐management components: smoking cessation (optional), self‐recognition of COPD exacerbations, use of a COPD exacerbation action plan, physical activity (optional), diet (optional), COPD medication intake (optional), alcohol (optional), psychosocial (optional) Self‐management topics: not reported Behavioural change techniques: 5 clusters: goals and planning, feedback and monitoring, social support, shaping knowledge, self‐belief |
Outcomes | 1. Quality of life (SF‐36 and SGRQ) 2. Patients' self‐management behaviour and knowledge (PIH scale) 3. Self‐efficacy (SEMCD) 4. Anxiety and depression (HADS, CES‐D and PCL‐C) 5. Well‐being (SWLS) 6. Hospital admissions |
Notes | Source of funding: this work was supported by the National Health and Medical Research Council (NHMRC) project grant ID490028, a Royal Hobart Hospital Research Foundation grant and a University of Tasmania Institutional Research Grant. Conflict of interest: Lung Foundation Australia/Boehringer Ingelheim chronic obstructive pulmonary disease (COPD) Research Fellowship for JW |